Drug · DIN 02517086
POMALIDOMIDE
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since September 9, 2024.
- Drug Identification Number (DIN)
- 02517086
- Company (DIN owner)
- Natco Pharma (Canada) IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Pomalidomide L04AX06
- Class
- Human
- Record last updated
- July 20, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| POMALIDOMIDE | 3 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 22, 2023: NOC 30192Abbreviated New Drug Submission (ANDS)
Other DINs named POMALIDOMIDE
- DIN 02517051 · Cancelled Pre Market
- DIN 02517078 · Cancelled Pre Market
- DIN 02517094 · Cancelled Pre Market